Compile Data Set for Download or QSAR
maximum 50k data
Found 38 Enz. Inhib. hit(s) with all data for entry = 182
TargetDual specificity mitogen-activated protein kinase kinase 1(Homo sapiens (Human))
Centaurus Biopharma

US Patent
LigandPNGBDBM204738((s)-6-(2-fluoro-4-iodophenylamino)-n-(2-hydroxybut...)
Affinity DataIC50: <100nMpH: 7.4 T: 2°CAssay Description:Compounds were diluted from DMSO stocks into 1× buffer (20 mM MOPS, PH 7.4, 5 mM MgCl2, 0.5 mM MnCl2, 100 uM Sodium Orthovanadate, 0.01% Triton X-100...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetDual specificity mitogen-activated protein kinase kinase 1(Homo sapiens (Human))
Centaurus Biopharma

US Patent
LigandPNGBDBM204784(6-(2-fluoro-4-iodophenylamino)-7-(3-hydroxy-3-(pip...)
Affinity DataIC50: <100nMpH: 7.4 T: 2°CAssay Description:Compounds were diluted from DMSO stocks into 1× buffer (20 mM MOPS, PH 7.4, 5 mM MgCl2, 0.5 mM MnCl2, 100 uM Sodium Orthovanadate, 0.01% Triton X-100...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetDual specificity mitogen-activated protein kinase kinase 1(Homo sapiens (Human))
Centaurus Biopharma

US Patent
LigandPNGBDBM204747(6-(2-chloro-4-iodophenylamino)-n-(2-hydroxyethoxy)...)
Affinity DataIC50: <100nMpH: 7.4 T: 2°CAssay Description:Compounds were diluted from DMSO stocks into 1× buffer (20 mM MOPS, PH 7.4, 5 mM MgCl2, 0.5 mM MnCl2, 100 uM Sodium Orthovanadate, 0.01% Triton X-100...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetDual specificity mitogen-activated protein kinase kinase 1(Homo sapiens (Human))
Centaurus Biopharma

US Patent
LigandPNGBDBM204731((s)-6-(2-fluoro-4-iodophenylamino)-n-(2-hydroxypro...)
Affinity DataIC50: <100nMpH: 7.4 T: 2°CAssay Description:Compounds were diluted from DMSO stocks into 1× buffer (20 mM MOPS, PH 7.4, 5 mM MgCl2, 0.5 mM MnCl2, 100 uM Sodium Orthovanadate, 0.01% Triton X-100...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetDual specificity mitogen-activated protein kinase kinase 1(Homo sapiens (Human))
Centaurus Biopharma

US Patent
LigandPNGBDBM204737((r)żn-(2,3-dihydroxypropoxy)-6-(2-fluoro-4-iodophe...)
Affinity DataIC50: <100nMpH: 7.4 T: 2°CAssay Description:Compounds were diluted from DMSO stocks into 1× buffer (20 mM MOPS, PH 7.4, 5 mM MgCl2, 0.5 mM MnCl2, 100 uM Sodium Orthovanadate, 0.01% Triton X-100...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetDual specificity mitogen-activated protein kinase kinase 1(Homo sapiens (Human))
Centaurus Biopharma

US Patent
LigandPNGBDBM204616(6-(2-fluoro-4-iodophenylamino)-n-(2-hydroxyethoxy)...)
Affinity DataIC50: <100nMpH: 7.4 T: 2°CAssay Description:Compounds were diluted from DMSO stocks into 1× buffer (20 mM MOPS, PH 7.4, 5 mM MgCl2, 0.5 mM MnCl2, 100 uM Sodium Orthovanadate, 0.01% Triton X-100...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetDual specificity mitogen-activated protein kinase kinase 1(Homo sapiens (Human))
Centaurus Biopharma

US Patent
LigandPNGBDBM204735(US9540396, 7 | n-(cyclopropylmethoxy)-6-(2-fluoro-...)
Affinity DataIC50: <100nMpH: 7.4 T: 2°CAssay Description:Compounds were diluted from DMSO stocks into 1× buffer (20 mM MOPS, PH 7.4, 5 mM MgCl2, 0.5 mM MnCl2, 100 uM Sodium Orthovanadate, 0.01% Triton X-100...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetDual specificity mitogen-activated protein kinase kinase 1(Homo sapiens (Human))
Centaurus Biopharma

US Patent
LigandPNGBDBM204736(6-(2-fluoro-4-iodophenylamino)-n-(1-hydroxy-2-meth...)
Affinity DataIC50: <100nMpH: 7.4 T: 2°CAssay Description:Compounds were diluted from DMSO stocks into 1× buffer (20 mM MOPS, PH 7.4, 5 mM MgCl2, 0.5 mM MnCl2, 100 uM Sodium Orthovanadate, 0.01% Triton X-100...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetDual specificity mitogen-activated protein kinase kinase 1(Homo sapiens (Human))
Centaurus Biopharma

US Patent
LigandPNGBDBM204732((s)-6-(2-fluoro-4-iodophenylamino)-n-(1-hydroxypro...)
Affinity DataIC50: <100nMpH: 7.4 T: 2°CAssay Description:Compounds were diluted from DMSO stocks into 1× buffer (20 mM MOPS, PH 7.4, 5 mM MgCl2, 0.5 mM MnCl2, 100 uM Sodium Orthovanadate, 0.01% Triton X-100...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetDual specificity mitogen-activated protein kinase kinase 1(Homo sapiens (Human))
Centaurus Biopharma

US Patent
LigandPNGBDBM204734(6-(2-fluoro-4-iodophenylamino)-n-(2-methoxyethoxy)...)
Affinity DataIC50: <500nMpH: 7.4 T: 2°CAssay Description:Compounds were diluted from DMSO stocks into 1× buffer (20 mM MOPS, PH 7.4, 5 mM MgCl2, 0.5 mM MnCl2, 100 uM Sodium Orthovanadate, 0.01% Triton X-100...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetDual specificity mitogen-activated protein kinase kinase 1(Homo sapiens (Human))
Centaurus Biopharma

US Patent
LigandPNGBDBM204729(6-(2-fluoro-4-iodophenylamino)-n-(2-hydroxyethoxy)...)
Affinity DataIC50: <500nMpH: 7.4 T: 2°CAssay Description:Compounds were diluted from DMSO stocks into 1× buffer (20 mM MOPS, PH 7.4, 5 mM MgCl2, 0.5 mM MnCl2, 100 uM Sodium Orthovanadate, 0.01% Triton X-100...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetDual specificity mitogen-activated protein kinase kinase 1(Homo sapiens (Human))
Centaurus Biopharma

US Patent
LigandPNGBDBM204782(6-(2-chloro-4-iodophenylamino)-n-(2-hydroxyethoxy)...)
Affinity DataIC50: <500nMpH: 7.4 T: 2°CAssay Description:Compounds were diluted from DMSO stocks into 1× buffer (20 mM MOPS, PH 7.4, 5 mM MgCl2, 0.5 mM MnCl2, 100 uM Sodium Orthovanadate, 0.01% Triton X-100...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetDual specificity mitogen-activated protein kinase kinase 1(Homo sapiens (Human))
Centaurus Biopharma

US Patent
LigandPNGBDBM204781(6-(2-chloro-4-iodophenylamino)-n-(3-hydroxypropyl)...)
Affinity DataIC50: <500nMpH: 7.4 T: 2°CAssay Description:Compounds were diluted from DMSO stocks into 1× buffer (20 mM MOPS, PH 7.4, 5 mM MgCl2, 0.5 mM MnCl2, 100 uM Sodium Orthovanadate, 0.01% Triton X-100...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetDual specificity mitogen-activated protein kinase kinase 1(Homo sapiens (Human))
Centaurus Biopharma

US Patent
LigandPNGBDBM204772(6-(2-fluoro-4-iodophenylamino)-n-(2-hydroxyethoxy)...)
Affinity DataIC50: <500nMpH: 7.4 T: 2°CAssay Description:Compounds were diluted from DMSO stocks into 1× buffer (20 mM MOPS, PH 7.4, 5 mM MgCl2, 0.5 mM MnCl2, 100 uM Sodium Orthovanadate, 0.01% Triton X-100...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetDual specificity mitogen-activated protein kinase kinase 1(Homo sapiens (Human))
Centaurus Biopharma

US Patent
LigandPNGBDBM204771(2-amino-6-(2-fluoro-4-iodophenylamino)-n-(2-hydrox...)
Affinity DataIC50: <500nMpH: 7.4 T: 2°CAssay Description:Compounds were diluted from DMSO stocks into 1× buffer (20 mM MOPS, PH 7.4, 5 mM MgCl2, 0.5 mM MnCl2, 100 uM Sodium Orthovanadate, 0.01% Triton X-100...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetDual specificity mitogen-activated protein kinase kinase 1(Homo sapiens (Human))
Centaurus Biopharma

US Patent
LigandPNGBDBM204770(6-(2-fluoro-4-iodophenylamino)-n-(2-hydroxyacetyl)...)
Affinity DataIC50: <500nMpH: 7.4 T: 2°CAssay Description:Compounds were diluted from DMSO stocks into 1× buffer (20 mM MOPS, PH 7.4, 5 mM MgCl2, 0.5 mM MnCl2, 100 uM Sodium Orthovanadate, 0.01% Triton X-100...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetDual specificity mitogen-activated protein kinase kinase 1(Homo sapiens (Human))
Centaurus Biopharma

US Patent
LigandPNGBDBM204768(2-((dimethylamino)methyl)-6-(2-fluoro-4-iodophenyl...)
Affinity DataIC50: <500nMpH: 7.4 T: 2°CAssay Description:Compounds were diluted from DMSO stocks into 1× buffer (20 mM MOPS, PH 7.4, 5 mM MgCl2, 0.5 mM MnCl2, 100 uM Sodium Orthovanadate, 0.01% Triton X-100...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetDual specificity mitogen-activated protein kinase kinase 1(Homo sapiens (Human))
Centaurus Biopharma

US Patent
LigandPNGBDBM204765((r)żn-(2,3-dihydroxypropoxy)-6-(2-fluoro-4-iodophe...)
Affinity DataIC50: <500nMpH: 7.4 T: 2°CAssay Description:Compounds were diluted from DMSO stocks into 1× buffer (20 mM MOPS, PH 7.4, 5 mM MgCl2, 0.5 mM MnCl2, 100 uM Sodium Orthovanadate, 0.01% Triton X-100...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetDual specificity mitogen-activated protein kinase kinase 1(Homo sapiens (Human))
Centaurus Biopharma

US Patent
LigandPNGBDBM204764(6-(2-fluoro-4-iodophenylamino)-n-(2-hydroxyethoxy)...)
Affinity DataIC50: <500nMpH: 7.4 T: 2°CAssay Description:Compounds were diluted from DMSO stocks into 1× buffer (20 mM MOPS, PH 7.4, 5 mM MgCl2, 0.5 mM MnCl2, 100 uM Sodium Orthovanadate, 0.01% Triton X-100...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetDual specificity mitogen-activated protein kinase kinase 1(Homo sapiens (Human))
Centaurus Biopharma

US Patent
LigandPNGBDBM204762(6-(2-fluoro-4-iodophenylamino)-n-(2-hydroxyethoxy)...)
Affinity DataIC50: <500nMpH: 7.4 T: 2°CAssay Description:Compounds were diluted from DMSO stocks into 1× buffer (20 mM MOPS, PH 7.4, 5 mM MgCl2, 0.5 mM MnCl2, 100 uM Sodium Orthovanadate, 0.01% Triton X-100...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetDual specificity mitogen-activated protein kinase kinase 1(Homo sapiens (Human))
Centaurus Biopharma

US Patent
LigandPNGBDBM204756(6-(2-fluoro-4-(methylthio)phenylamino)-n-(2-hydrox...)
Affinity DataIC50: <500nMpH: 7.4 T: 2°CAssay Description:Compounds were diluted from DMSO stocks into 1× buffer (20 mM MOPS, PH 7.4, 5 mM MgCl2, 0.5 mM MnCl2, 100 uM Sodium Orthovanadate, 0.01% Triton X-100...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetDual specificity mitogen-activated protein kinase kinase 1(Homo sapiens (Human))
Centaurus Biopharma

US Patent
LigandPNGBDBM204755(6-(2-fluoro-4-iodophenylamino)-n-(2-hydroxyethoxy)...)
Affinity DataIC50: <500nMpH: 7.4 T: 2°CAssay Description:Compounds were diluted from DMSO stocks into 1× buffer (20 mM MOPS, PH 7.4, 5 mM MgCl2, 0.5 mM MnCl2, 100 uM Sodium Orthovanadate, 0.01% Triton X-100...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetDual specificity mitogen-activated protein kinase kinase 1(Homo sapiens (Human))
Centaurus Biopharma

US Patent
LigandPNGBDBM204744(US9540396, 14 | n-ethoxy-6-(2-fluoro-4-iodophenyla...)
Affinity DataIC50: <500nMpH: 7.4 T: 2°CAssay Description:Compounds were diluted from DMSO stocks into 1× buffer (20 mM MOPS, PH 7.4, 5 mM MgCl2, 0.5 mM MnCl2, 100 uM Sodium Orthovanadate, 0.01% Triton X-100...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetDual specificity mitogen-activated protein kinase kinase 1(Homo sapiens (Human))
Centaurus Biopharma

US Patent
LigandPNGBDBM204742(6-(2-fluoro-4-iodophenylamino)-n-methoxy-5-methyl-...)
Affinity DataIC50: <500nMpH: 7.4 T: 2°CAssay Description:Compounds were diluted from DMSO stocks into 1× buffer (20 mM MOPS, PH 7.4, 5 mM MgCl2, 0.5 mM MnCl2, 100 uM Sodium Orthovanadate, 0.01% Triton X-100...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetDual specificity mitogen-activated protein kinase kinase 1(Homo sapiens (Human))
Centaurus Biopharma

US Patent
LigandPNGBDBM204741(6-(4-bromo-2-chlorophenylamino)-n-(2-hydroxyethoxy...)
Affinity DataIC50: <1.00E+3nMpH: 7.4 T: 2°CAssay Description:Compounds were diluted from DMSO stocks into 1× buffer (20 mM MOPS, PH 7.4, 5 mM MgCl2, 0.5 mM MnCl2, 100 uM Sodium Orthovanadate, 0.01% Triton X-100...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetDual specificity mitogen-activated protein kinase kinase 1(Homo sapiens (Human))
Centaurus Biopharma

US Patent
LigandPNGBDBM204758(6-(2-fluoro-4-iodophenylamino)-n-(2-hydroxyethoxy)...)
Affinity DataIC50: <1.00E+3nMpH: 7.4 T: 2°CAssay Description:Compounds were diluted from DMSO stocks into 1× buffer (20 mM MOPS, PH 7.4, 5 mM MgCl2, 0.5 mM MnCl2, 100 uM Sodium Orthovanadate, 0.01% Triton X-100...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetDual specificity mitogen-activated protein kinase kinase 1(Homo sapiens (Human))
Centaurus Biopharma

US Patent
LigandPNGBDBM204773(6-(2-fluoro-4-iodophenylamino)-n-(2-hydroxyethoxy)...)
Affinity DataIC50: <1.00E+3nMpH: 7.4 T: 2°CAssay Description:Compounds were diluted from DMSO stocks into 1× buffer (20 mM MOPS, PH 7.4, 5 mM MgCl2, 0.5 mM MnCl2, 100 uM Sodium Orthovanadate, 0.01% Triton X-100...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetDual specificity mitogen-activated protein kinase kinase 1(Homo sapiens (Human))
Centaurus Biopharma

US Patent
LigandPNGBDBM204745(6-(2-fluoro-4-iodophenylamino)-5-methyl-4-oxo-4,5-...)
Affinity DataIC50: <1.00E+3nMpH: 7.4 T: 2°CAssay Description:Compounds were diluted from DMSO stocks into 1× buffer (20 mM MOPS, PH 7.4, 5 mM MgCl2, 0.5 mM MnCl2, 100 uM Sodium Orthovanadate, 0.01% Triton X-100...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetDual specificity mitogen-activated protein kinase kinase 1(Homo sapiens (Human))
Centaurus Biopharma

US Patent
LigandPNGBDBM204746(US9540396, 16 | n-(2,3-dihydroxypropyl)-6-(2-fluor...)
Affinity DataIC50: <1.00E+3nMpH: 7.4 T: 2°CAssay Description:Compounds were diluted from DMSO stocks into 1× buffer (20 mM MOPS, PH 7.4, 5 mM MgCl2, 0.5 mM MnCl2, 100 uM Sodium Orthovanadate, 0.01% Triton X-100...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetDual specificity mitogen-activated protein kinase kinase 1(Homo sapiens (Human))
Centaurus Biopharma

US Patent
LigandPNGBDBM204783(6-(2-fluoro-4-iodophenylamino)-n-(2-hydroxyethoxy)...)
Affinity DataIC50: <1.00E+3nMpH: 7.4 T: 2°CAssay Description:Compounds were diluted from DMSO stocks into 1× buffer (20 mM MOPS, PH 7.4, 5 mM MgCl2, 0.5 mM MnCl2, 100 uM Sodium Orthovanadate, 0.01% Triton X-100...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetDual specificity mitogen-activated protein kinase kinase 1(Homo sapiens (Human))
Centaurus Biopharma

US Patent
LigandPNGBDBM204757(6-(2-chloro-4-(methylthio)phenylamino)-n-(2-hydrox...)
Affinity DataIC50: <1.00E+3nMpH: 7.4 T: 2°CAssay Description:Compounds were diluted from DMSO stocks into 1× buffer (20 mM MOPS, PH 7.4, 5 mM MgCl2, 0.5 mM MnCl2, 100 uM Sodium Orthovanadate, 0.01% Triton X-100...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetDual specificity mitogen-activated protein kinase kinase 1(Homo sapiens (Human))
Centaurus Biopharma

US Patent
LigandPNGBDBM204763(6-(2-fluoro-4-iodophenylamino)-n-(2-hydroxyethoxy)...)
Affinity DataIC50: <1.00E+4nMpH: 7.4 T: 2°CAssay Description:Compounds were diluted from DMSO stocks into 1× buffer (20 mM MOPS, PH 7.4, 5 mM MgCl2, 0.5 mM MnCl2, 100 uM Sodium Orthovanadate, 0.01% Triton X-100...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetDual specificity mitogen-activated protein kinase kinase 1(Homo sapiens (Human))
Centaurus Biopharma

US Patent
LigandPNGBDBM204730(6-(4-bromo-2-fluorophenylamino)-n-(2-hydroxyethoxy...)
Affinity DataIC50: <1.00E+4nMpH: 7.4 T: 2°CAssay Description:Compounds were diluted from DMSO stocks into 1× buffer (20 mM MOPS, PH 7.4, 5 mM MgCl2, 0.5 mM MnCl2, 100 uM Sodium Orthovanadate, 0.01% Triton X-100...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetDual specificity mitogen-activated protein kinase kinase 1(Homo sapiens (Human))
Centaurus Biopharma

US Patent
LigandPNGBDBM204740(6-(2,4-dichlorophenylamino)-n-(2-hydroxyethoxy)-5-...)
Affinity DataIC50: <1.00E+4nMpH: 7.4 T: 2°CAssay Description:Compounds were diluted from DMSO stocks into 1× buffer (20 mM MOPS, PH 7.4, 5 mM MgCl2, 0.5 mM MnCl2, 100 uM Sodium Orthovanadate, 0.01% Triton X-100...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetDual specificity mitogen-activated protein kinase kinase 1(Homo sapiens (Human))
Centaurus Biopharma

US Patent
LigandPNGBDBM204777(6-(2-fluoro-4-iodophenylamino)-n-(2-hydroxyethoxy)...)
Affinity DataIC50: <1.00E+4nMpH: 7.4 T: 2°CAssay Description:Compounds were diluted from DMSO stocks into 1× buffer (20 mM MOPS, PH 7.4, 5 mM MgCl2, 0.5 mM MnCl2, 100 uM Sodium Orthovanadate, 0.01% Triton X-100...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetDual specificity mitogen-activated protein kinase kinase 1(Homo sapiens (Human))
Centaurus Biopharma

US Patent
LigandPNGBDBM204759(6-(2-fluoro-4-iodophenylamino)-n-(2-hydroxyethoxy)...)
Affinity DataIC50: <1.00E+4nMpH: 7.4 T: 2°CAssay Description:Compounds were diluted from DMSO stocks into 1× buffer (20 mM MOPS, PH 7.4, 5 mM MgCl2, 0.5 mM MnCl2, 100 uM Sodium Orthovanadate, 0.01% Triton X-100...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetDual specificity mitogen-activated protein kinase kinase 1(Homo sapiens (Human))
Centaurus Biopharma

US Patent
LigandPNGBDBM204769(6-(2-fluoro-4-iodophenylamino)-n-(2-hydroxyethoxy)...)
Affinity DataIC50: <1.00E+4nMpH: 7.4 T: 2°CAssay Description:Compounds were diluted from DMSO stocks into 1× buffer (20 mM MOPS, PH 7.4, 5 mM MgCl2, 0.5 mM MnCl2, 100 uM Sodium Orthovanadate, 0.01% Triton X-100...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetDual specificity mitogen-activated protein kinase kinase 1(Homo sapiens (Human))
Centaurus Biopharma

US Patent
LigandPNGBDBM204754(6-(2-fluoro-4-iodophenylamino)-n-(3-hydroxypropyl)...)
Affinity DataIC50: <1.00E+4nMpH: 7.4 T: 2°CAssay Description:Compounds were diluted from DMSO stocks into 1× buffer (20 mM MOPS, PH 7.4, 5 mM MgCl2, 0.5 mM MnCl2, 100 uM Sodium Orthovanadate, 0.01% Triton X-100...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent